|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2009-9-16
|
|
pubmed:abstractText |
As the treatment of Philadelphia positive (Ph+) leukemias in the era of imatinib continues to evolve, the role of allogeneic hematopoietic cell transplantation (allogeneic-HCT) in first remission is becoming more unclear.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1545-5017
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
53
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
992-5
|
|
pubmed:meshHeading |
pubmed-meshheading:19621426-Canada,
pubmed-meshheading:19621426-Data Collection,
pubmed-meshheading:19621426-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:19621426-Humans,
pubmed-meshheading:19621426-Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
pubmed-meshheading:19621426-Physician's Practice Patterns,
pubmed-meshheading:19621426-Physicians,
pubmed-meshheading:19621426-Piperazines,
pubmed-meshheading:19621426-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:19621426-Pyrimidines,
pubmed-meshheading:19621426-Siblings,
pubmed-meshheading:19621426-Tissue Donors,
pubmed-meshheading:19621426-Transplantation, Homologous,
pubmed-meshheading:19621426-United States
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
The treatment of pediatric Philadelphia positive (Ph+) leukemias in the imatinib era.
|
|
pubmed:affiliation |
Division of Pediatric Hematology/Oncology/Blood and Marrow Transplantation, University of Minnesota Children's Hospital-Fairview, Minneapolis, Minnesota 55455, USA. burke283@umn.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
